Casdin Capital as of Sept. 30, 2019
Portfolio Holdings for Casdin Capital
Casdin Capital holds 33 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spark Therapeutics | 9.1 | $91M | 863k | 104.93 | |
| Invitae (NVTAQ) | 7.4 | $74M | 3.8M | 19.27 | |
| Sage Therapeutics (SAGE) | 7.3 | $73M | 400k | 183.09 | |
| Blueprint Medicines (BPMC) | 6.9 | $69M | 940k | 73.47 | |
| Codexis (CDXS) | 6.8 | $68M | 5.1M | 13.37 | |
| Myokardia | 6.5 | $64M | 1.1M | 57.78 | |
| Bluebird Bio | 5.6 | $56M | 613k | 91.82 | |
| Fate Therapeutics (FATE) | 5.2 | $52M | 2.6M | 20.30 | |
| Sarepta Therapeutics (SRPT) | 5.1 | $51M | 880k | 57.84 | |
| Alnylam Pharmaceuticals (ALNY) | 4.8 | $48M | 600k | 80.42 | |
| Biolife Solutions (BLFS) | 4.0 | $40M | 2.4M | 16.62 | |
| Magenta Therapeutics | 3.1 | $31M | 3.0M | 10.26 | |
| Voyager Therapeutics (VYGR) | 3.1 | $31M | 1.1M | 27.22 | |
| Agios Pharmaceuticals (AGIO) | 3.0 | $30M | 935k | 32.40 | |
| Audentes Therapeutics | 2.4 | $24M | 860k | 28.09 | |
| Illumina (ILMN) | 2.2 | $22M | 60k | 368.15 | |
| GenMark Diagnostics | 2.2 | $22M | 3.4M | 6.49 | |
| Gritstone Oncology Ord (GRTSQ) | 2.0 | $20M | 1.8M | 11.14 | |
| Sangamo Biosciences (SGMO) | 1.6 | $17M | 1.5M | 11.33 | |
| Global Blood Therapeutics In | 1.6 | $16M | 300k | 52.60 | |
| Homology Medicines | 1.5 | $15M | 820k | 17.78 | |
| Adaptive Biotechnologies Cor (ADPT) | 1.3 | $13M | 463k | 29.02 | |
| Editas Medicine (EDIT) | 1.2 | $12M | 415k | 28.61 | |
| Alector (ALEC) | 1.2 | $12M | 811k | 14.42 | |
| Constellation Pharmceticls I | 1.0 | $9.8M | 1.5M | 6.46 | |
| Twist Bioscience Corp (TWST) | 0.9 | $8.7M | 300k | 29.01 | |
| Denali Therapeutics (DNLI) | 0.8 | $8.3M | 400k | 20.76 | |
| Caredx (CDNA) | 0.7 | $7.2M | 1.0M | 7.20 | |
| Fulcrum Therapeutics (FULC) | 0.5 | $5.3M | 844k | 6.24 | |
| Deciphera Pharmaceuticals | 0.3 | $3.4M | 100k | 33.94 | |
| Stoke Therapeutics (STOK) | 0.2 | $2.5M | 130k | 19.07 | |
| Turning Point Therapeutics I | 0.2 | $2.4M | 75k | 32.56 | |
| Orchard Therapeutics Plc ads | 0.1 | $1.4M | 310k | 4.51 |
